Markedly increased risk of myeloid neoplasia among clonal hematopoiesis carriers with multiple TET2 mutations
Blood Advances
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Markedly increased risk of myeloid neoplasia among clonal hematopoiesis carriers with multiple TET2 mutations. // Blood Advances. – URL: https://www.sciencedirect.com/science/article/pii/S2473952926006610?dgcid=rss_sd_all
Markedly increased risk of myeloid neoplasia among clonal hematopoiesis carriers with multiple TET2 mutations. Blood Advances. https://www.sciencedirect.com/science/article/pii/S2473952926006610?dgcid=rss_sd_all
“Markedly increased risk of myeloid neoplasia among clonal hematopoiesis carriers with multiple TET2 mutations.” Blood Advances.
@article{article38111,
title = {Markedly increased risk of myeloid neoplasia among clonal hematopoiesis carriers with multiple TET2 mutations},
journal = {Blood Advances},
url = {https://www.sciencedirect.com/science/article/pii/S2473952926006610?dgcid=rss_sd_all}
}